Back to Search

HANNAH STRONG, D.O.

D.O.

Pediatrics Physician

NPI: 1700291911Individual

Specialties, Licenses & Credentials

Pediatrics PhysicianPrimary

Pediatrics

Code: 208000000X

036144425(IL)2017037077(MO)

Research & Publications (14)

Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.
PMID 19243834·Ophthalmology·2009
8-other
Self-presentational motives in eating disordered behavior: a known groups difference approach.
PMID 17174857·Eat Behav·2007
8-other
Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
PMID 15824216·Arch Ophthalmol·2005
3-trial
Verteporfin in Photodynamic Therapy: report no. 5.
PMID 15522385·Ophthalmology·2004
8-other
Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3.
PMID 15059708·Am J Ophthalmol·2004
8-other
Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.
PMID 12967792·Am J Ophthalmol·2003
4-observational
Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2.
PMID 12963608·Arch Ophthalmol·2003
8-other
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
PMID 12689884·Ophthalmology·2003
3-trial
Duration of skin photosensitivity and incidence of photosensitivity reactions after administration of verteporfin.
PMID 12476093·Retina·2002
3-trial
Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
PMID 12427056·Arch Ophthalmol·2002
3-trial
The use of medications for cognitive enhancement.
PMID 11237304·Can J Neurol Sci·2001
6-review
The question of price in medical practice.
PMID 11234643·S Afr Med J·2000
8-other
Showing your true colours.
PMID 11081098·S Afr Med J·2000
8-other
A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.
PMID 10721954·Arch Ophthalmol·2000
5-case

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
2409 HYDE PARK RD
JEFFERSON CITY, MO 65109

Location

Practice Location

2409 HYDE PARK RD, JEFFERSON CITY, MO
(573) 635-6217

Quick Facts

NPI
1700291911
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
14

Are you this provider?

Claim Your Profile